Tactile Systems Technology, Inc. (TCMD)

Market Cap	229.23M
Revenue (ttm)	293.16M
Net Income (ttm)	16.20M
Shares Out	23.25M
EPS (ttm)	0.66
PE Ratio	14.93
Forward PE	15.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,943,831
Open	8.82
Previous Close	13.94
Day's Range	8.76 - 10.02
52-Week Range	8.61 - 21.10
Beta	1.05
Analysts	Hold
Price Target	16.00 (+62.27%)
Earnings Date	May 5, 2025

About TCMD

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Nimbl, a pneumatic compression platform for the trea...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 28, 2016
• Employees: 1,037
• Stock Exchange: NASDAQ
• Ticker Symbol: TCMD
• Website: https://tactilemedical.com

Financial Performance

In 2024, TCMD's revenue was $292.98 million, an increase of 6.76% compared to the previous year's $274.42 million. Earnings were $16.96 million, a decrease of -40.52%.

Analyst Forecast

According to 3 analysts, the average rating for TCMD stock is "Hold." The 12-month stock price forecast is $16.0, which is an increase of 62.27% from the latest price.

Price Target

$16.0

(62.27% upside)

Analyst Consensus: Hold